GlaxoSmithKline Pharmaceuticals has announced a final dividend of Rs. 42 per share, up from Rs. 32 last year, pending shareholder approval.

The record date for entitlement is set, with payment to follow.

The company posted standalone FY profit of Rs. 919 Cr and consolidated profit of Rs. 928 Cr, signaling solid earnings and improved profitability—positive news for shareholders.